Investigational drugs in thrombotic thrombocytopenic purpura.
about
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.
P2860
Investigational drugs in thrombotic thrombocytopenic purpura.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Investigational drugs in thrombotic thrombocytopenic purpura.
@ast
Investigational drugs in thrombotic thrombocytopenic purpura.
@en
type
label
Investigational drugs in thrombotic thrombocytopenic purpura.
@ast
Investigational drugs in thrombotic thrombocytopenic purpura.
@en
prefLabel
Investigational drugs in thrombotic thrombocytopenic purpura.
@ast
Investigational drugs in thrombotic thrombocytopenic purpura.
@en
P2860
P1476
Investigational drugs in thrombotic thrombocytopenic purpura
@en
P2093
Carlo L Balduini
P2860
P304
P356
10.1517/13543784.2011.588599
P407
P50
P577
2011-06-10T00:00:00Z